Pharma, NBFCs see fresh mutual fund buying in AprilIndian fund managers focused on defensive stocks in April. Pharmaceuticals saw increased investment due to opportunities like the semagluti...
14 May, 2026, 06.26 AM IST
Stocks in news: Paytm, Bajaj Auto, L&T, Bharti Airtel, Hero MotoCorpMarkets closed lower amid global headwinds and geopolitical worries. Several companies like Paytm, Bajaj Auto, and L&T are in focus due to ...
06 May, 2026, 06.33 AM IST
Emcure eyes India growth, global deals amid strong demandEmcure Pharmaceuticals is boosting domestic expansion, R&D, and manufacturing. The company is also exploring acquisition opportunities in I...
05 May, 2026, 10.59 PM IST
Ahead of Market: 10 things that will decide stock market action on WednesdayIndian markets closed lower amid selling in financial, consumer and realty stocks, with Nifty and Sensex declining. Technical indicators si...
05 May, 2026, 09.31 PM IST
Adani Ports, Tata Motors and Siemens Energy witness block deal action on MondayInstitutional investors injected over Rs 7,400 crore into Adani Ports and Special Economic Zone (APSEZ) on Monday through significant block...
04 May, 2026, 10.07 PM IST
Mauritius-based entity sells Rs 289 crore worth shares in Emcure Pharmaceuticals via block deal; Norges Bank acquirerEmcure Pharmaceuticals saw a significant block deal where BC Investments IV Limited sold 18 lakh shares for Rs 289 crore to Norges Bank. Th...
29 Apr, 2026, 09.51 PM IST
‘Doing what I do best’: Namita Thapar shares new reel amid controversyEmcure Pharmaceuticals' Namita Thapar shared a health awareness video amid controversy over her namaz remarks. Meanwhile, Lenskart faced ba...
21 Apr, 2026, 07.04 PM IST
Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
21 Apr, 2026, 08.37 AM IST
'I don’t care...': Namita Thapar reacts to online trolling over her video on health benefits of namazNamita Thapar has responded to online trolling over her video on the health benefits of namaz. Her comments come amid wider corporate contr...
20 Apr, 2026, 10.08 AM IST
Emcure cuts semaglutide injection price by average 47%The starting dose price is cut by 55% to Rs 3,999 per month (four weekly doses). The innovator semaglutide is available in a once-weekly pe...
02 Apr, 2026, 07.58 PM IST
Emcure slashes prices of weight management drug Poviztra by up to 55%Emcure Pharmaceuticals is making its weight management drug Poviztra more accessible. The price of the semaglutide injection will be cut by...
02 Apr, 2026, 07.39 PM IST
Emcure Pharmaceuticals partners with Gilead Sciences to produce HIV prevention drug LenacapavirEmcure Pharmaceuticals has partnered with Gilead Sciences Ireland UC to manufacture and distribute generic lenacapavir for HIV prevention a...
03 Oct, 2024, 10.57 AM IST
Emcure Pharmaceuticals IPO share allotment likely on Monday. Here's how you can check the status.07 Jul, 2024, 11.21 AM IST
Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2. Check GMP and other detailsEmcure Pharmaceuticals' IPO has been oversubscribed nearly three times as of Thursday, the second day of bidding. The bidding concludes on ...
05 Jul, 2024, 11.33 AM IST
Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issueEmcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximatel...
01 Jul, 2024, 02.01 PM IST
Emcure Pharma announces price band for Rs 1,952-crore IPO at Rs 960-1,008/share. Check GMP, other detailsEmcure Pharmaceuticals has announced its initial public offering (IPO) with a price band of Rs 960 to Rs 1,008 per equity share. The subscr...
28 Jun, 2024, 02.18 PM IST
Emcure Pharmaceuticals acquires Canadian company and its marketing arm MarcanMarcan Pharma has over 60 approved products that are mainly available via McKesson and Kohl & Frisch, among other wholesalers, it claimed.
18 Jan, 2016, 05.09 PM IST